176 related articles for article (PubMed ID: 11505513)
1. [Effect of actarit combination therapy in patients with active rheumatoid arthritis resistant to gold agents].
Sakurai T; Iso T; Inoue H; Sano K; Takeuchi K; Takagishi K
Ryumachi; 2001 Jun; 41(3):635-45. PubMed ID: 11505513
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
Vlak T; Stambuk B
Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
[TBL] [Abstract][Full Text] [Related]
4. [An evaluation of efficacy of minocycline as an anti-rheumatic drug in patients with active and refractory rheumatoid arthritis].
Kawanaka N; Yamamura M; Hashimoto H; Okamoto H; Morita Y; Kawashima M; Aita T; Okamoto A; Makino H
Ryumachi; 1998 Dec; 38(6):801-9. PubMed ID: 10047718
[TBL] [Abstract][Full Text] [Related]
5. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN
J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751
[TBL] [Abstract][Full Text] [Related]
6. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
[TBL] [Abstract][Full Text] [Related]
8. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
[TBL] [Abstract][Full Text] [Related]
9. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L
J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308
[TBL] [Abstract][Full Text] [Related]
10. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
El Miedany Y; Youssef SS; El Gaafary M
J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
[TBL] [Abstract][Full Text] [Related]
11. Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
O'Dell JR; Petersen K; Leff R; Palmer W; Schned E; Blakely K; Haire C; Fernandez A
J Rheumatol; 2006 Feb; 33(2):213-8. PubMed ID: 16358366
[TBL] [Abstract][Full Text] [Related]
12. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
[TBL] [Abstract][Full Text] [Related]
13. Auranofin: first choice for remission-inducing drug (RID) therapy in rheumatoid arthritis?
Bandilla K; Missler B; Klein-Reesink B
Scand J Rheumatol Suppl; 1986; 63():47-54. PubMed ID: 3474777
[TBL] [Abstract][Full Text] [Related]
14. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
Sokka T; Pincus T
J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial.
Furuzawa-Carballeda J; Cabral AR; Zapata-Zuñiga M; Alcocer-Varela J
J Rheumatol; 2003 Feb; 30(2):256-9. PubMed ID: 12563677
[TBL] [Abstract][Full Text] [Related]
16. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
[TBL] [Abstract][Full Text] [Related]
17. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
Gordon P; West J; Jones H; Gibson T
J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
[TBL] [Abstract][Full Text] [Related]
18. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M
J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the clinico-therapeutic response to oral gold salts in patients with rheumatoid arthritis].
Giordano N; Biasi G; Morozzi G; Taddeo A; Frati E; Marcolongo R; Paternò E
Clin Ter; 1989 Mar; 128(5):343-6. PubMed ID: 2524321
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
